Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ipsen
Roswell Park Cancer Institute
University of Arizona
Case Comprehensive Cancer Center
OHSU Knight Cancer Institute
Vanderbilt-Ingram Cancer Center